Mawer Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,847,934
Closed -$223M 112
2023
Q3
$223M Sell
12,847,934
-345,921
-3% -$7.21M 1.19% 24
2023
Q2
$275M Sell
13,193,855
-80,795
-0.6% -$1.76M 1.44% 21
2023
Q1
$312M Buy
13,274,650
+94,845
+0.7% +$2.55M 1.7% 18
2022
Q4
$368M Buy
13,179,805
+2,381,668
+22% +$60.9M 2.08% 14
2022
Q3
$253M Sell
10,798,137
-50,385
-0.5% -$1.52M 1.53% 19
2022
Q2
$366M Buy
10,848,522
+2,553,301
+31% +$89.4M 2.08% 15
2022
Q1
$290M Buy
+8,295,221
New +$284M 1.38% 21

Other funds holding OGN

Mawer Investment Management's OGN Position: Q4 2023 in Review

Mawer Investment Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 12,847,934 shares — an estimated $223M sold.

Mawer Investment Management first reported a position in OGN in Q1 2022 and held it in 7 quarters. The position peaked at $368M in Q4 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Mawer Investment Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Mawer Investment Management sold 12,847,934 Organon & Co shares in Q4 2023, an estimated $223M.
  • Mawer Investment Management first reported a position in Organon & Co in Q1 2022 and held it in 7 quarters.
  • Mawer Investment Management's Organon & Co position peaked at $368M in Q4 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Mawer Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.